EGFR and adenocarcinoma: Masai et al. reported that patients with usual interstitial pneumonia (UIP)-adenocarcinoma (n = 44) had a lower EGFR mutation rate (2.3% vs. 45.6%, P < 0.01) than patients with non-UIP-adenocarcinoma (n = 2265)38.